Medicare Enrolled
Dr. Edward Houser, MD
Urology Physician · Durham, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Houser from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Houser?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Houser
Dr. Edward Houser is an urology physician in Durham, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Houser performed 3,422 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Houser received a total of $14,284 from 67 pharmaceutical and/or device companies across 692 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Houser is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 26% volume in NC
$14,284 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗3,422
Medicare services
Top 26% in NC for urology physician
Not available
Unique patients (not deduplicated)
$21
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
1,700 | $0 | $2 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
527 | $2 | $3 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
350 | $60 | $96 |
| PSA test (prostate cancer screening) | 235 | $18 | $25 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
136 | $81 | $138 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
119 | $34 | $60 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
93 | $21 | $32 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $110 | $192 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
49 | $7 | $14 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
49 | $179 | $252 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $26 | $35 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
20 | $25 | $28 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
16 | $311 | $434 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
14 | $64 | $88 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
11 | $196 | $350 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
11 | $135 | $170 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
0.5% high complexity
52.1% medium
47.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,284
Total received (2018-2024)
Avg $2,041/year across 7 years
Top 10% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
692
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,601
2023
$2,125
2022
$2,594
2021
$2,508
2020
$766
2019
$1,818
2018
$1,872
Payments by company (2024)
Dendreon Pharmaceuticals LLC
$688
Sumitomo Pharma America, Inc.
$452
Janssen Biotech, Inc.
$265
PROCEPT BioRobotics Corporation
$173
Bayer Healthcare Pharmaceuticals Inc.
$166
PROGENICS PHARMACEUTICALS, INC.
$113
Endo USA, Inc.
$111
PFIZER INC.
$110
Ferring Pharmaceuticals Inc.
$80
UROGEN PHARMA, INC.
$80
Novartis Pharmaceuticals Corporation
$71
Endo Pharmaceuticals Inc.
$55
Teleflex LLC
$47
Merck Sharp & Dohme LLC
$47
ABBVIE INC.
$38
ConvaTec Inc.
$35
Boston Scientific Corporation
$20
Antares Pharma, Inc.
$20
Ethicon US, LLC
$16
Axonics, Inc.
$13
Top 3 companies account for 54.0% of 2024 payments
All-time payments by company (2018-2024) ›
Dendreon Pharmaceuticals LLC
$2,660
Janssen Biotech, Inc.
$1,594
Astellas Pharma US Inc
$1,528
Sumitomo Pharma America, Inc.
$904
Endo Pharmaceuticals Inc.
$871
PFIZER INC.
$645
Myovant Sciences Inc.
$468
Avadel Specialty Pharmaceuticals, LLC
$345
NeoTract Inc.
$286
Bayer HealthCare Pharmaceuticals Inc.
$280
Antares Pharma, Inc.
$273
UROVANT SCIENCES INC
$273
Bayer Healthcare Pharmaceuticals Inc.
$272
Amgen Inc.
$224
Ferring Pharmaceuticals Inc.
$224
PROCEPT BioRobotics Corporation
$208
ABBVIE INC.
$193
UroGen Pharma, Inc.
$162
Teleflex LLC
$155
UROGEN PHARMA, INC.
$152
Ethicon US, LLC
$129
180 Medical, Inc.
$124
Merck Sharp & Dohme Corporation
$119
AbbVie Inc.
$115
GENZYME CORPORATION
$114
PROGENICS PHARMACEUTICALS, INC.
$113
Clarus Therapeutics Inc.
$112
Endo USA, Inc.
$111
Merck Sharp & Dohme LLC
$106
Photocure Inc
$100
BOSTON SCIENTIFIC CORPORATION
$99
Caldera Medical, Inc
$81
AbbVie, Inc.
$79
Progenics Pharmaceuticals, Inc.
$75
Janssen Products, LP
$75
Axonics, Inc.
$75
Tolmar, Inc.
$75
Novartis Pharmaceuticals Corporation
$71
Boston Scientific Corporation
$68
Supernus Pharmaceuticals, Inc.
$65
Sun Pharmaceutical Industries Inc.
$59
TOLMAR Pharmaceuticals, Inc.
$56
Laborie Medical Technologies Corp.
$51
Olympus America Inc.
$45
ConvaTec Inc.
$35
Agiliti Surgical, Inc.
$32
Retrophin, Inc.
$32
Allergan, Inc.
$31
DENTSPLY IH Inc.
$31
Mission Pharmacal Company
$29
Palette Life Sciences, Inc.
$23
Blue Earth Diagnostics Limited
$23
COLOPLAST CORP
$19
Ambu Inc.
$19
Heron Therapeutics, Inc.
$16
Travere Therapeutics, Inc.
$16
Axonics Modulation Technologies, Inc.
$15
Myriad Genetic Laboratories, Inc.
$15
Medtronic, Inc.
$15
Davol Inc.
$14
Aytu BioScience, Inc
$14
SUN PHARMACEUTICAL INDUSTRIES INC.
$13
Hollister Incorporated
$13
Coloplast Corp
$13
Allergan Inc.
$12
Egalet US Inc
$12
NxThera, Inc.
$10
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ABIRATERONE ACETATE · ADSTILADRIN · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · ARISTA AH FLEXITIP · Axonics · Axonics r-SNM System · Axumin · BOTOX · BRACAnalysis CDx · CLENPIQ · CURE CATHETER · CURE ULTRA CATHETER · CYSVIEW · Cysview · DERMABOND PRINEO · Desara · Digital Flexible Ureteroscopes · EDEX · ELIGARD · ERLEADA · ETHICON · Erleada · FIRMAGON · GEMTESA · GENERAL EMBOLICS · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · GentleCath · INTERSTIM · Infyna Chic · JATENZO · JELMYTO · JEVTANA · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · LoFric · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · PROVENGE · PYLARIFY · Prineo 42 · Prolia · REZUM · Rezum · SPEEDICATH · SPRIX · STRATAFIX · SURGICEL NU-KNIT · SUTENT · SWISS LITHOCLAST TRILOGY · ShockPulse - SE · Soltive TFL PREMIUM LASER SYSTEM · SpeediCath · TITAN · TOVIAZ · Thiola · Titan · UROLIFT · Uribel · UroLift · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · YONSA · ZYTIGA · Zynrelef · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
73
County median income
$79,501
Nearest hospital to ZIP centroid (approximate)
NORTH CAROLINA SPECIALTY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Houser is a clinical cardiology specialist, with above-average Medicare volume (top 26% in NC), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Houser experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Houser performed 1,700 contrast dye for imaging (iodine-based) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Houser receive payments from pharmaceutical companies?
Yes. Dr. Houser received a total of $14,284 from 67 companies across 692 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Houser's costs compare to other urology physicians in Durham?
Dr. Houser's average Medicare payment per service is $21. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Houser) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Durham
Browse urology physicians in Durham ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology